Johnson Matthey PLC (LON:JMAT) insider Robert MacLeod purchased 12 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was purchased at an average price of GBX 3,225 ($42.14) per share, for a total transaction of £387 ($505.68).
Shares of JMAT stock opened at GBX 3,131 ($40.91) on Monday. The company has a quick ratio of 0.95, a current ratio of 1.64 and a debt-to-equity ratio of 50.40. The firm has a market cap of $6.06 billion and a P/E ratio of 14.59. The business’s 50 day moving average is GBX 3,218. Johnson Matthey PLC has a 52 week low of GBX 2,574 ($33.63) and a 52 week high of GBX 3,783 ($49.43).
The business also recently announced a dividend, which will be paid on Tuesday, August 6th. Shareholders of record on Thursday, June 6th will be issued a dividend of GBX 62.25 ($0.81) per share. This is an increase from Johnson Matthey’s previous dividend of $23.25. This represents a yield of 2.04%. The ex-dividend date of this dividend is Thursday, June 6th. Johnson Matthey’s dividend payout ratio (DPR) is 0.40%.
A number of analysts recently weighed in on JMAT shares. Liberum Capital reiterated a “buy” rating on shares of Hotel Chocolat Group in a research report on Wednesday, July 17th. UBS Group reiterated a “neutral” rating on shares of CAIXABANK/ADR in a research report on Thursday. Credit Suisse Group set a €100.00 ($116.28) price target on shares of Safran and gave the company a “sell” rating in a research report on Friday, May 31st. Berenberg Bank downgraded shares of to a “hold” rating and cut their price target for the company from GBX 265 ($3.46) to GBX 248 ($3.24) in a research report on Monday, June 3rd. Finally, HSBC downgraded shares of Banco Macro from a “buy” rating to a “hold” rating in a research report on Wednesday, June 5th. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of GBX 3,738.33 ($48.85).
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also: What is dollar cost averaging (DCA)?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.